Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (271-280 of 386) with videos related to

Pageof 39
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcomaMichael D Prados, Susan M Chang, Nicholas Butowski, et al.
Cancer|April 27, 2021
Loneliness and symptom burden in oncology patients during the COVID-19 pandemicChristine Miaskowski, Steven M Paul, Karin Snowberg, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupBrian M Alexander, Paul D Brown, Manmeet S Ahluwalia, et al.
Pageof 39

Showing results (271-280 of 386) with videos related to

Sort By:
Pageof 39
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcomaMichael D Prados, Susan M Chang, Nicholas Butowski, et al.
Cancer|April 27, 2021
Loneliness and symptom burden in oncology patients during the COVID-19 pandemicChristine Miaskowski, Steven M Paul, Karin Snowberg, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
The Lancet. Oncology|August 30, 2024
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect groupPhilipp Karschnia, Jasper K W Gerritsen, Nico Teske, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
The Lancet. Oncology|January 6, 2018
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working groupBrian M Alexander, Paul D Brown, Manmeet S Ahluwalia, et al.
Pageof 39